期刊文献+

GC-MS法测定艾拉莫德中磺酸酯杂质 被引量:4

Determination of methanesulfonates impurities in Iguratimod by GC-MS
下载PDF
导出
摘要 目的建立气相色谱质谱方法测定艾拉莫德中甲磺酸甲酯(MMS)、甲磺酸乙酯(EMS)、甲磺酸异丙酯(IMS)的含量。方法采用柱前衍生化,将甲磺酸甲酯(MMS)、甲磺酸乙酯(EMS)、甲磺酸异丙酯(IMS)分别衍生成碘甲烷、碘乙烷和碘代异丙烷,采用GC-MS法进行测定。结果 MMS、EMS、IMS分别在8.10×10^(-2)^(-1).53、4.89×10^(-2)^(-1).55、1.02×10^(-1)^(-1).51 mg·L^(-1)内,线性关系良好(r>0.99);MMS、EMS、IMS检测限分别为1.62×10^(-2)、7.30×10^(-3)、2.29×10^(-2) mg·L^(-1),定量限分别为8.10×10^(-2)、4.89×10^(-2)、1.02×10^(-1) mg·L^(-1);在50%、100%、150%水平回收率均在80%~120%内。结论该方法准确可靠,灵敏度高,可用于测定艾拉莫德中甲磺酸甲酯、甲磺酸乙酯、甲磺酸异丙酯的含量。 Objective To establish a method for determination of methyl methanesulfonate(MMS), ethyl methanesulfonate(EMS) and isopropyl methanesulfonate(IMS) in Iguratimod by GC-MS.Methods Method The methyl methanesulfonate(MMS), ethyl methanesulfonate(EMS) and isopropyl methanesulfonate(IMS) were derived into methyl iodide, ethyl iodide and isopropyl iodide by Pre-column derivatisation, respectively, and determined by GC-MS.Results The calibration curves for MMS,EMS and IMS were good linear in the range of 8.10×10^(-2)^(-1).53,4.89×10^(-2)^(-1).55,1.02×10^(-1)^(-1).51 μg·mL^(-1), respectively(r>0.99).The limit of detection of MMS, EMS and IMS were 1.62×10^(-2),7.30×10^(-3) and 2.29×10^(-2) μg·mL^(-1), respectively, the limit of quantitation were 8.10×10^(-2), 4.89×10^(-2),1.02×10^(-1) μg·mL^(-1),respectively;the recoveries at 50%,100%,150% levels were between 80% and 120%.Conclusion The method is accurate, reliable and sensitive, and it′s suitable for the determination of methyl methanesulfonate, ethyl methanesulfonate and isopropyl methanesulfonate in Iguratimod.
作者 李旦 张鹏 LI Dan;ZHANG Peng(Wuya College of Innovation.Shenyang Pharmaceutical University,Shenyang 110016,China)
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2021年第5期467-471,共5页 Journal of Shenyang Pharmaceutical University
关键词 艾拉莫德 气相色谱-质谱 衍生化 甲磺酸酯 iguratimod GC-MS derivatisation methanesulfonates
  • 相关文献

参考文献4

二级参考文献20

  • 1全球医药快讯[J].世界临床药物,2009(12):578-579. 被引量:6
  • 2GIORDANI A,KOBEL W,GALLY H.Overall impact of the regulatory requirements for Genotoxic impurities on the drug development process[J].Eur J Pharm Sci,2011,43(1/2):1-15.
  • 3U.S.Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research(CDER).Recommended Approaches to Integration of Genetic Toxicology Study Results[EB/OL].[2013-10-15].http://www.fda.gov/down loads/Drugs/Guidance Compliance Regulatory Information/Guidances/UCM079257.pdf.
  • 4European Medicines Agency.Questions and answers on the'Guideline on the limits of genotoxic impurities'[EB/OL].[2013-10-15].http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002907.pdf.
  • 5ICH Harmonised Tripartite Guidelin.Assessment and control of DNA Reactive(Mutagenic)impurities in Pharaceuticals to limit potential carcinogenic risk M7[EB/OL].[2013-10-16].http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Multidisciplinary/M7/M7_Step_4.pdf.
  • 6KAKADIYA P R,REDDY B P,SINGH V,et a1.Low level determinations of methyl methanesulfonate and ethyl methanesulfonate impurities in Lopinavir and Ritonavir active pharmaceutical ingredients by LC-MS/MS using electrospray ionization[J].J Pharm Biomed Anal,2011,55(2):379-384.
  • 7MONTESANO M A,WHITEHEAD J R D,JAYATILAKA N K,et a1.Measurement of methyl methanesulfonate in human plasma and breast milk samples using high-performance liquid chromatography-atmospheric pressure chemicalionization-tandem mass spectrometry[J].J Pharm Biomed Anal,2010,52(2):260-264.
  • 8AN V,SUN M,BAI L,et a1.A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances[J].J Pharm Biomed Anal,2008,48(3):1006-1010.
  • 9Hauel N, Ries U, Priepke H, et al, Disubstituted bicycle heterocycles, their production and use as medicaments: WO, 9837075 [P]. 1998-02-16.
  • 10Jayaraman VR, Patel S, Mistry S, et al. An improved process for the preparation of dabigatran etexilate mesylate: WO, 2014020555 [P]. 2014-02-06.

共引文献16

同被引文献45

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部